ArsenalBio
Ken Drazan MD is Chairman, CEO, and co-founder of ArsenalBio. Immediately prior to Arsenal, Ken held the positions of President and Chief Business Officer of GRAIL (Acquired by ILMN). Prior to GRAIL, Ken founded and was a Board Director of Verb Surgical (Acquired by JNJ). Ken also co-founded private equity firm Bertram Capital with $1.9B AUM. Ken is a Board certified liver transplant surgeon with previous faculty appointments at Stanford and UCLA.
This person is not in any offices
ArsenalBio
ArsenalBio’s mission is to develop efficacious and safe cellular therapies for patients with chronic diseases, initially cancer.